O	O	O	0	9	Inducible	Inducible	B-NP	JJ	O	3	NMOD	O
O	O	O	10	17	nuclear	nuclear	I-NP	JJ	B-protein	3	NMOD	B-protein
O	O	O	18	24	factor	factor	I-NP	NN	I-protein	19	SUB	I-protein
O	O	O	25	32	binding	bind	B-VP	VBG	O	3	NMOD	O
O	O	O	33	35	to	to	B-PP	TO	O	4	VMOD	O
O	O	O	36	39	the	the	B-NP	DT	O	9	NMOD	O
T4,T5	B-Entity,B-Entity	B-Entity,B-Entity	40	45	kappa	kappa	I-NP	NN	B-DNA	9	NMOD	B-DNA
T4,T5	I-Entity,I-Entity	I-Entity,I-Entity	46	47	B	B	I-NP	NN	I-DNA	9	NMOD	I-DNA
T4	I-Entity	I-Entity	48	56	elements	element	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	57	59	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	60	63	the	the	B-NP	DT	O	15	NMOD	O
T6	B-Entity	B-Entity	64	69	human	human	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T6	I-Entity	I-Entity	70	86	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	15	NMOD	I-DNA
T6	I-Entity	I-Entity	87	92	virus	virus	I-NP	NN	I-DNA	15	NMOD	I-DNA
T6	I-Entity	I-Entity	93	101	enhancer	enhancer	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	O	102	104	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	105	106	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	O	107	112	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	113	116	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	117	119	be	be	I-VP	VB	O	19	VC	O
O	O	O	120	127	blocked	block	I-VP	VBN	O	20	VC	O
O	O	O	128	130	by	by	B-PP	IN	O	21	VMOD	O
O	O	O	131	142	cyclosporin	cyclosporin	B-NP	NN	O	24	NMOD	O
O	O	O	143	144	A	A	I-NP	NN	O	22	PMOD	O
O	O	O	145	147	in	in	B-PP	IN	O	24	NMOD	O
O	O	O	148	149	a	a	B-NP	DT	O	30	NMOD	O
O	O	O	150	156	signal	signal	I-NP	NN	O	30	NMOD	O
O	O	O	156	157	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	O	157	166	dependent	dependent	I-NP	JJ	O	30	NMOD	O
O	O	O	167	173	manner	manner	I-NP	NN	O	25	PMOD	O
O	O	O	173	174	.	.	O	.	O	19	P	O

O	O	O	176	187	Cyclosporin	Cyclosporin	B-NP	NN	O	2	NMOD	O
O	O	O	188	189	A	A	I-NP	NN	O	6	SUB	O
O	O	O	190	191	(	(	O	(	O	5	DEP	O
O	O	O	191	194	CsA	CsA	B-NP	NN	O	5	DEP	O
O	O	O	194	195	)	)	O	)	O	2	NMOD	O
O	O	O	196	198	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	199	206	thought	think	I-VP	VBN	O	6	VC	O
O	O	O	207	209	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	210	215	exert	exert	I-VP	VB	O	7	VMOD	O
O	O	O	216	219	its	its	B-NP	PRP$	O	12	NMOD	O
O	O	O	220	237	immunosuppressive	immunosuppressive	I-NP	JJ	O	12	NMOD	O
O	O	O	238	245	effects	effect	I-NP	NNS	O	9	OBJ	O
O	O	O	246	248	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	249	259	inhibiting	inhibit	B-VP	VBG	O	13	PMOD	O
O	O	O	260	263	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	264	274	expression	expression	I-NP	NN	O	14	OBJ	O
O	O	O	275	277	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	278	279	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	280	288	distinct	distinct	I-NP	JJ	O	20	NMOD	O
O	O	O	289	292	set	set	I-NP	NN	O	17	PMOD	O
O	O	O	293	295	of	of	B-PP	IN	O	20	NMOD	O
T7	B-Entity	B-Entity	296	306	lymphokine	lymphokine	B-NP	NN	B-DNA	23	NMOD	B-DNA
T7	I-Entity	I-Entity	307	312	genes	gene	I-NP	NNS	I-DNA	21	PMOD	I-DNA
O	O	O	313	318	which	which	B-NP	WDT	O	23	NMOD	O
O	O	O	319	322	are	be	B-VP	VBP	O	24	SBAR	O
O	O	O	323	330	induced	induce	I-VP	VBN	O	25	VC	O
O	O	O	331	335	upon	upon	B-PP	IN	O	26	VMOD	O
O	O	O	336	337	T	T	B-NP	NN	O	31	NMOD	O
O	O	O	337	338	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	O	338	342	cell	cell	I-NP	NN	O	31	NMOD	O
O	O	O	343	353	activation	activation	I-NP	NN	O	27	PMOD	O
O	O	O	353	354	,	,	O	,	O	20	P	O
O	O	O	355	360	among	among	B-PP	IN	O	14	VMOD	O
O	O	O	361	365	them	them	B-NP	PRP	O	33	PMOD	O
O	O	O	366	369	the	the	B-NP	DT	O	36	NMOD	O
O	O	O	370	374	gene	gene	I-NP	NN	O	33	PMOD	O
O	O	O	375	381	coding	cod	B-VP	VBG	O	36	NMOD	O
O	O	O	382	385	for	for	B-PP	IN	O	37	VMOD	O
T1	B-Protein	B-Protein	386	397	interleukin	interleukin	B-NP	NN	B-protein	40	NMOD	B-protein
T1	I-Protein	I-Protein	397	398	-	-	B-NP	HYPH	I-protein	38	PMOD	I-protein
T1	I-Protein	I-Protein	398	399	2	2	I-NP	CD	I-protein	40	NMOD	I-protein
O	O	O	399	400	.	.	O	.	O	6	P	O

O	O	O	401	403	In	In	B-PP	IN	O	14	VMOD	O
O	O	O	404	412	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	412	413	,	,	O	,	O	14	P	O
O	O	O	414	417	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	418	428	activation	activation	I-NP	NN	O	14	SUB	O
O	O	O	429	431	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	432	435	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	436	441	human	human	I-NP	JJ	O	10	NMOD	O
O	O	O	442	458	immunodeficiency	immunodeficiency	I-NP	NN	O	10	NMOD	O
O	O	O	459	464	virus	virus	I-NP	NN	O	6	PMOD	O
O	O	O	465	466	(	(	O	(	O	13	DEP	O
O	O	O	466	469	HIV	HIV	B-NP	NN	O	13	DEP	O
O	O	O	469	470	)	)	O	)	O	10	NMOD	O
O	O	O	471	473	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	474	483	partially	partially	I-VP	RB	O	14	VMOD	O
O	O	O	484	494	suppressed	suppress	I-VP	VBN	O	14	VC	O
O	O	O	494	495	.	.	O	.	O	14	P	O

O	O	O	496	498	To	To	B-VP	TO	O	3	VMOD	O
O	O	O	499	505	better	well	I-VP	RBR	O	3	VMOD	O
O	O	O	506	516	understand	understand	I-VP	VB	O	13	VMOD	O
O	O	O	517	520	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	521	530	molecular	molecular	I-NP	JJ	O	6	NMOD	O
O	O	O	531	541	mechanisms	mechanism	I-NP	NNS	O	3	OBJ	O
O	O	O	542	552	underlying	underlie	B-VP	VBG	O	6	NMOD	O
O	O	O	553	564	suppression	suppression	B-NP	NN	O	7	OBJ	O
O	O	O	565	567	by	by	B-PP	IN	O	8	NMOD	O
O	O	O	568	571	CsA	CsA	B-NP	NN	O	9	PMOD	O
O	O	O	571	572	,	,	O	,	O	13	P	O
O	O	O	573	575	we	we	B-NP	PRP	O	13	SUB	O
O	O	O	576	580	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	581	593	investigated	investigate	I-VP	VBN	O	13	VC	O
O	O	O	594	597	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	598	605	effects	effect	I-NP	NNS	O	14	OBJ	O
O	O	O	606	608	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	609	613	this	this	B-NP	DT	O	19	NMOD	O
O	O	O	614	618	drug	drug	I-NP	NN	O	17	PMOD	O
O	O	O	619	621	on	on	B-PP	IN	O	16	NMOD	O
O	O	O	622	635	transcription	transcription	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	636	643	factors	factor	I-NP	NNS	I-protein	20	PMOD	I-protein
O	O	O	644	646	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	647	648	T	T	B-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	O	649	654	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	654	655	.	.	O	.	O	13	P	O

O	O	O	656	660	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	661	663	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	664	670	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	671	675	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	676	679	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	680	689	formation	formation	I-NP	NN	O	21	NMOD	O
O	O	O	690	692	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	693	696	two	two	B-NP	CD	O	16	NMOD	O
O	O	O	697	705	distinct	distinct	I-NP	JJ	O	16	NMOD	O
O	O	O	706	713	mitogen	mitogen	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	713	714	-	-	O	HYPH	I-protein	16	NMOD	I-protein
O	O	O	714	723	inducible	inducible	B-NP	JJ	I-protein	13	NMOD	I-protein
T8,T9	B-Entity,B-Entity	B-Entity,B-Entity	724	727	DNA	DNA	I-NP	NN	I-protein	16	NMOD	I-protein
T8	I-Entity	I-Entity	727	728	-	-	B-VP	HYPH	I-protein	16	NMOD	I-protein
T8	I-Entity	I-Entity	728	735	binding	bind	B-NP	VBG	I-protein	16	NMOD	I-protein
T8	I-Entity	I-Entity	736	745	complexes	complex	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	745	746	,	,	O	,	O	21	P	O
O	O	O	747	750	the	the	B-NP	DT	O	21	NMOD	O
T10	B-Entity	B-Entity	751	756	kappa	kappa	I-NP	NN	B-protein	21	NMOD	B-protein
T10	I-Entity	I-Entity	757	758	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
T10	I-Entity	I-Entity	759	766	complex	complex	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	767	773	within	within	B-PP	IN	O	21	NMOD	O
O	O	O	774	777	the	the	B-NP	DT	O	25	NMOD	O
T11	B-Entity	B-Entity	778	781	HIV	HIV	I-NP	NN	B-DNA	25	NMOD	B-DNA
T11	I-Entity	I-Entity	782	790	enhancer	enhancer	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	O	791	794	and	and	O	CC	O	31	NMOD	O
O	O	O	795	798	the	the	B-NP	DT	O	31	NMOD	O
T2	B-Protein	B-Protein	799	803	NFAT	NFAT	I-NP	NN	B-protein	31	NMOD	B-protein
T2	I-Protein	I-Protein	803	804	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
T2	I-Protein	I-Protein	804	805	1	1	I-NP	CD	I-protein	31	NMOD	I-protein
T12	B-Entity	B-Entity	806	813	complex	complex	I-NP	NN	I-protein	39	SUB	I-protein
O	O	O	814	820	within	within	B-PP	IN	O	31	NMOD	O
O	O	O	821	824	the	the	B-NP	DT	O	37	NMOD	O
T3	B-Protein	B-Protein	825	836	interleukin	interleukin	I-NP	NN	B-DNA	37	NMOD	B-DNA
T3	I-Protein	I-Protein	836	837	-	-	I-NP	HYPH	I-DNA	37	NMOD	I-DNA
T3	I-Protein	I-Protein	837	838	2	2	I-NP	CD	I-DNA	37	NMOD	I-DNA
T13	B-Entity	B-Entity	839	847	enhancer	enhancer	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	O	847	848	,	,	O	,	O	31	P	O
O	O	O	849	851	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	852	861	inhibited	inhibit	I-VP	VBN	O	39	VC	O
O	O	O	862	864	in	in	B-PP	IN	O	40	VMOD	O
O	O	O	865	868	the	the	I-PP	DT	O	43	NMOD	O
O	O	O	869	877	presence	presence	I-PP	NN	O	41	PMOD	O
O	O	O	878	880	of	of	I-PP	IN	O	43	NMOD	O
O	O	O	881	884	CsA	CsA	B-NP	NN	O	44	PMOD	O
O	O	O	884	885	.	.	O	.	O	3	P	O

O	O	O	886	889	The	The	B-NP	DT	O	0	ROOT	O
T14	B-Entity	B-Entity	890	895	kappa	kappa	I-NP	NN	O	1	NMOD	O
T14	I-Entity	I-Entity	896	897	B	B	I-NP	NN	O	11	SUB	O
O	O	O	897	898	-	-	O	HYPH	O	11	P	O
O	O	O	898	905	binding	binding	B-NP	NN	O	6	NMOD	O
O	O	O	906	914	activity	activity	I-NP	NN	O	11	SUB	O
O	O	O	915	919	with	with	B-PP	IN	O	6	NMOD	O
O	O	O	920	923	the	the	B-NP	DT	O	10	NMOD	O
T15	B-Entity	B-Entity	924	927	HIV	HIV	I-NP	NN	B-DNA	10	NMOD	B-DNA
T15	I-Entity	I-Entity	928	936	enhancer	enhancer	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	937	939	is	be	B-VP	VBZ	O	2	SBAR	O
O	O	O	940	949	inhibited	inhibit	I-VP	VBN	O	11	VC	O
O	O	O	950	954	only	only	B-SBAR	RB	O	14	DEP	O
O	O	O	955	957	if	if	I-SBAR	IN	O	11	VMOD	O
O	O	O	958	960	it	it	B-NP	PRP	O	16	SUB	O
O	O	O	961	963	is	be	B-VP	VBZ	O	14	SBAR	O
O	O	O	964	973	activated	activate	I-VP	VBN	O	16	VC	O
O	O	O	974	977	via	via	B-PP	IN	O	17	VMOD	O
O	O	O	978	981	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	982	989	mitogen	mitogen	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	990	1008	phytohemagglutinin	phytohemagglutinin	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1009	1016	whereas	whereas	B-PP	IN	O	11	VMOD	O
O	O	O	1017	1024	phorbol	phorbol	B-NP	NN	O	25	NMOD	O
O	O	O	1025	1034	myristate	myristate	I-NP	NN	O	25	NMOD	O
O	O	O	1035	1042	acetate	acetate	I-NP	NN	O	28	NMOD	O
O	O	O	1042	1043	-	-	B-VP	HYPH	O	28	NMOD	O
O	O	O	1043	1051	mediated	mediate	B-NP	VBN	O	28	NMOD	O
O	O	O	1052	1062	activation	activation	I-NP	NN	O	29	SUB	O
O	O	O	1063	1065	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	1066	1076	completely	completely	B-ADJP	RB	O	31	AMOD	O
O	O	O	1077	1088	insensitive	insensitive	I-ADJP	JJ	O	29	PRD	O
O	O	O	1089	1091	to	to	B-PP	TO	O	31	AMOD	O
O	O	O	1092	1095	the	the	B-NP	DT	O	34	NMOD	O
O	O	O	1096	1100	drug	drug	I-NP	NN	O	32	PMOD	O
O	O	O	1100	1101	.	.	O	.	O	1	P	O

O	O	O	1102	1106	This	This	B-NP	DT	O	2	SUB	O
O	O	O	1107	1115	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	O	1116	1117	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	1118	1123	model	model	I-NP	NN	O	2	OBJ	O
O	O	O	1124	1126	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	1127	1132	which	which	B-NP	WDT	O	5	PMOD	O
O	O	O	1133	1145	functionally	functionally	B-NP	RB	O	8	AMOD	O
O	O	O	1146	1163	indistinguishable	indistinguishable	I-NP	JJ	O	11	NMOD	O
T16	B-Entity	B-Entity	1164	1169	kappa	kappa	I-NP	NN	B-protein	11	NMOD	B-protein
T16	I-Entity	I-Entity	1170	1171	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
T16	I-Entity	I-Entity	1172	1181	complexes	complex	I-NP	NNS	I-protein	12	SUB	I-protein
O	O	O	1182	1185	can	can	B-VP	MD	O	5	SBAR	O
O	O	O	1186	1188	be	be	I-VP	VB	O	12	VC	O
O	O	O	1189	1198	activated	activate	I-VP	VBN	O	13	VC	O
O	O	O	1199	1202	via	via	B-PP	IN	O	14	VMOD	O
O	O	O	1203	1206	two	two	B-NP	CD	O	18	NMOD	O
O	O	O	1207	1215	separate	separate	I-NP	JJ	O	18	NMOD	O
O	O	O	1216	1224	pathways	pathway	I-NP	NNS	O	15	PMOD	O
O	O	O	1225	1227	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1228	1234	signal	signal	B-NP	NN	O	21	NMOD	O
O	O	O	1235	1247	transduction	transduction	I-NP	NN	O	19	PMOD	O
O	O	O	1248	1263	distinguishable	distinguishable	B-ADJP	JJ	O	21	NMOD	O
O	O	O	1264	1266	by	by	B-PP	IN	O	22	AMOD	O
O	O	O	1267	1270	CsA	CsA	B-NP	NN	O	23	PMOD	O
O	O	O	1270	1271	.	.	O	.	O	2	P	O
